Compare Humana Inc (HUM) vs Lumen Technologies Inc (LUMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Lumen Technologies Inc — how do they compare? Humana Inc trades at $374.25 (market cap $46.31B), while Lumen Technologies Inc trades at $6.38 (market cap $6.85B). The key difference: Humana Inc is far larger — about 6.8× Lumen Technologies Inc's market cap, and Humana Inc pays a 0.92% dividend while Lumen Technologies Inc pays none. Which is the better fit depends on your goals.
| HUM | LUMN | |
|---|---|---|
Market Cap | $46.31B | $6.85B |
Sector | Health | Media |
52-Week High | $409.42 | $11.83 |
52-Week Low | $163.67 | $3.95 |
Enterprise Value | $53.67B | $18.47B |
Dividend Yield | 0.92% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
LUMN trades at $6.24, up 5.76% in the last session, with a bearish technical outlook but mixed fundamental signals. The stock shows negative profitability with a net income margin of -8.65% and ROE of -78.94%, though Q2 2026 earnings beat estimates with a narrower loss. Strategic revenue growth of 14.1% highlights progress in digital transformation, but high debt of $17.49 billion remains a concern. Recent CEO share purchases and analyst downgrades reflect conflicting sentiment.
The outlook is cautious due to persistent losses and heavy debt, offset by potential from digital initiatives. Investment opportunity lies in successful execution of the transformation strategy, but risks include revenue declines and interest burdens. Analysts maintain a neutral stance with a $7.38 price target, suggesting limited upside from current levels amid operational challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Lumen Technologies Inc
With 450,000 route miles of fiber, including over 35,000 route miles of subsea fiber connecting Europe, Asia, and Latin America, Lumen Technologies is one of the United States' largest telecommunications carriers serving global enterprises. Its merger with Level 3 further shifted the company's operations toward businesses (over 70% of revenue) and away from its legacy consumer business. Lumen offers businesses a full menu of communications services, providing colocation and data center services, data transportation, and end-user phone and internet service. On the consumer side, Lumen provides broadband and phone service across 37 states, where it has 4.5 million broadband customers.
Read more on LUMN →
